Clinical trials
Phase 3 Immune System Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Terminated | 7 |
| Recruiting | 6 |
| Active, not recruiting | 5 |
| Enrolling by invitation | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 4 |
| AstraZeneca | 3 |
| Eli Lilly and Company | 3 |
| Ellodi Pharmaceuticals, LP | 3 |
| Viatris Innovation GmbH | 3 |
| Bristol-Myers Squibb | 2 |
| National Center for Research Resources (NCRR) | 2 |
| Novartis Pharmaceuticals | 2 |
| Takeda | 2 |
| Adienne SA | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immune System Diseases | 36 |
| Autoimmune Diseases | 16 |
| Connective Tissue Diseases | 10 |
| Lupus Erythematosus, Systemic | 10 |
| Hypersensitivity | 8 |
| Hypersensitivity, Immediate | 7 |
| Hematologic Diseases | 6 |
| Dermatitis, Atopic | 5 |
| Eczema | 5 |
| Skin Diseases | 5 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.